Wedged hepatic vein pressure (WHVP): Ready for prime time

Hepatology

Volumn 43, Issue 3, 2006, Pages 405-406

  Boyer, Thomas D ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLEEDING; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; EDITORIAL; HEMODYNAMIC MONITORING; HEPATIC VEIN; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEDICAL EDUCATION; MEDICARE; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROGNOSIS; REIMBURSEMENT; RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL; VARICOSIS; VENOUS PRESSURE; WEDGED HEPATIC VEIN PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATIC VEINS; HUMANS; LIVER CIRCULATION; LIVER CIRRHOSIS; PREDICTIVE VALUE OF TESTS; VENOUS PRESSURE;

EID: 33645221135     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21118     Document Type: Editorial

References (16)

1. Perello A, Escorsell A, Bru C, Gilaber R, Moitinho E, Garcia-Pagan J, et al. Wedge hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. HEPATOLOGY 1999;30:1393-1397.
2. Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977;72:584-589.
3. Thalheimer U, Mela M, Patch D, Burroughs AK. Targeting portal pressure measurements: A critical reappraisal. HEPATOLOGY 2004;39:286-290.
4. Boyer TD. Changing clinical practice with measurements of portal pressure. HEPATOLOGY 2004;39:283-285.
5. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952-954.
6. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-655.
7. Villanueva C, Lopez-Balaguer JM, Aracil C, Kolle L, Gonzalez B, Minana J, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 2004;40:757-765.
8. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara G, Jiménez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. HEPATOLOGY 2004;40:793-801.
9. Huet PM, Pomier-Layrargues G. The hepatic venous pressure gradient: "Remixed and revisited" HEPATOLOGY 2004;39:295-298.
10. Blasco A, Forns X, Carrion J, Garcia-Pagan JC, Gilabert R, Rimola A, et al. Hepatic venous pressure gradient identifies patients at risk for severe hepatitis C recurrence after liver transplantation. HEPATOLOGY 2006;43:492-499.
11. Groszmann R, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-2251.
12. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003;38:1449-1457.
13. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, ; the milder the disease. J Hepatol 2003;39:239-244.
14. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: Anything worth doing should be done right. HEPATOLOGY 2004;39:280-282.
15. Raines DL, Dupont AW, Arguedas MR. Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Aliment Pharmacol Ther 2004;19:571-581.
16. Imperiale TF, Chalasani N, Klein RW. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis. Am J Gastroenterol 2003;98:2742-2750.